CaliPharms and Pacific Cannabis Growers Execute Acquisition

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
56
CaliPharms and Pacific Cannabis Growers Execute Acquisition Term Sheet

RIVERSIDE, CA--(Marketwired - Mar 16, 2017) - CaliPharms, Inc. ( OTC PINK : KGET )

CaliPharms, Inc. ( OTC PINK : KGET ), a Company operating in the California Medicinal Cannabis industry, publicly traded under its former name "Kleangas Energy Technologies, Inc.," is pleased to announce it has signed a non-binding term sheet with Pacific Cannabis Growers, a Humboldt County California Medical Cannabis Farm. ( www.pcgrowers.com )

Joshua Clark, President of Pacific Cannabis Growers, stated, "Pacific Cannabis Growers is very excited about becoming a part of CaliPharms. The benefits of forming this business relationship are outstanding; allowing us to focus on expansion while retaining crop quality. CaliPharms' long-term goals coincide exactly with ours. We are looking for sustained growth, new product development, and to establish our cannabis brands in the market. We couldn't be more pleased to be joining this rapidly growing team of cannabis professionals."

CaliPharms CEO Bo Linton stated, "This is the second medical cannabis farm in Northern California that CaliPharms has successfully negotiated to purchase. CaliPharms purchased Country Junction Farms as a 51% owned subsidiary, and we now expect to complete a similar type acquisition for Pacific Cannabis Growers." Linton continued, "Our acquisition model is built for success as we do not have to pay any upfront cash for the acquisition. CaliPharms will use its 51% ownership to pay towards the purchase price and supplementing the payments with preferred stock. This model makes the acquisition candidate and CaliPharms true partners, each depending on the other for success. It is a mutually beneficial relationship that builds value for the shareholder. We also structured the purchase price to fluctuate based on actual profits calculated at the end of 12 months with a unilateral unwind provision good for 1 year. The total buyout if completed will be over a 60 month period."

CaliPharms' long-term business plan includes acquiring numerous cannabis production facilities and product lines. This will allow us to supply our other business ventures with the raw materials needed to make award winning cannabis products, and to create a new market suppling other canna-ventures with the raw material they need to produce their products. Securing CaliPharms cannabis supply/production capability is our top priority. This will help establish CaliPharms as an industry leader in the near future.

Pacific Cannabis Growers' permit type (Mixed-Light) will allow for multiple harvest year round, in fully automated greenhouses, giving this acquisition additional value for CaliPharms.

2017 Forward Looking Income Projections for the Farm (The following are projections provided by the acquisition candidate. CaliPharms does not guarantee the projected results if the acquisition is completed.)

The farm will be operating a 10,000 sq ft "mixed light" commercial cannabis cultivation permit. *Mixed light is growing in greenhouse with artificial light supplementation this allows for multiple harvests through the year. 

1. Projected Primary Harvest: April - October

A growing method of centering each plant in a 6x6 area will amount to a total of 228 plants with an average yield of 3.5lbs per plant of flower and 3.5 of trim, with the right genetics. *Current wholesale price per lb of flower= $1250.00 *Current wholesale price per lb of trim= $50.00

228 x 3.5 lbs = 973 lbs

973 lbs x $1250.00*Wholesale flower price= 1,216,250.00   1,216,250.00
  +  
973 lbs x 50.00*Wholesale Trim Price= 48,650   0,048,650.00
  =  
Estimated Primary Harvest Fair Market Amount:   1,264,900.00
     

2. Projected Secondary Harvest: Nov - March

2017 is the first growing year on this new site, typically there would be 3 harvests annually, but for this initial year buildout of greenhouses after the primary harvest will limit us to only one additional harvest. Secondary harvest typically are about 60% less total harvest weight than a primary harvest. Smaller plants are utilized but the canopy sq ft used remains the same. *Currently off season fresh medical marijuana demands a premium price with an additional $250.00 added per lb at the wholesale level.

973 lbs - 60% = 389.2 lbs of secondary harvest flowers, and 389.2 lbs of trim.

389.2 lbs x 1500.00*Premium Off season price= 583,800.00   583,800.00
  +  
389.2 lbs x 50.00*Wholesale Trim Price= 19,460.00   19,460.00
     
Estimated Secondary Harvest Fair Market Amount:   603,260.00
     

3. Projected Primary and Secondary Harvest Totals:

2017 total estimated primary harvest value =   1,264,900.00
  +  
2017 total estimates secondary harvest value =   603,260.00
     
Estimated total 2017 Gross Harvest/Income value =   1,868,160.00
     

For up to date information on the company please follow us @

facebook.com/CaliPharms twitter.com/CaliPharms

About CaliPharms, Inc.

CaliPharms, Inc., trading under the symbol (KGET) which trades under its former name "Kleangas Energy Technologies, Inc." is a medical marijuana-cannabis business. The Company operates through its 51% owned subsidiary County Junction Farms, Inc. within the State of California. CaliPharms is a wholesale distributor of THC and CBD concentrate powders. The second tier of development for the company will be to expand into other sectors that support the legalized cannabis industry. The company intends to expand its operations as the laws for each individual State change and allow.

About Country Junction Farms, Inc.

Founded in 2010, Country Junction Farms is a fully permitted cultivator of medical cannabis within the State of California.

Safe Harbor Statement:

Safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by phrases such as CaliPharms or KGET or its management "believes," "expects," "anticipates," "foresees," "forecasts," "estimates" or other words or phrases of similar import. Similarly, statements herein that describe the Company's business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. Investment into a microcap company is a high risk investment and it should only be considered if you are able to afford a total loss of the investment. Laws and Regulations of Marijuana are currently in direct contradiction between California and Federal Law and these factors should be a part of your consideration when making an investment into KGET.

Company Contact: CaliPharms, Inc. (KGET) www.CaliPharmsInc.com facebook.com/CaliPharms twitter.com/CaliPharms Telephone 1-949-800-6645 Email: info@CaliPharmsInc.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

U.S. Green Beret's Mission: Clearing Landmines in Ukraine

Updated Category News Views 1

The Rise of "Safe Ground" on Prime Video This isn't your typical feel-good story—it’s about grit and the unending fight for 'normalcy' where war left scars. Safe Ground, now streaming on Prime Video, showcases Ryan Hendrickson, a U.S. Army Green Beret whose story takes a sharp turn after stepping on an IED in 2010. The day he almost became just another statistic...

Continue Reading
Countries Eye New Investment Paths at CIFIT 2026

Updated Category News Views 4

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Continue Reading
Protecting Teeth: Insights from Endodontist Dr. Joubert

Updated Category News Views 4

Preserving Our Natural Chompers Digging into the details of endodontic care, you realize how it's the unsung hero in the dental world. And let's face it, teeth don't get happier on their own when there's a problem on the inside. Dr. Christopher Joubert, a wiz on the endodontic front, spills the beans over at HelloNation about how essential these practices are in keeping...

Continue Reading
ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 6

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 9

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 9

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading
Ajman Spotlights Tourism at Arabian Travel Market 2026

Updated Category News Views 2

Ajman: A Tourism Gem in the Making Swinging into the Arabian Travel Market 2026, Ajman isn't just a footnote in the UAE's tourism playbook anymore, it's gunning for the spotlight. There's a flurry of activity as the Ajman Department of Tourism, Culture and Media rolls up its sleeves to flaunt the emirate's kaleidoscope of attractions to the world's tourism brass. Going...

Continue Reading
PureHealth's Acid Reflux Solutions: An Investor's Insight

Updated Category News Views 2

Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...

Continue Reading
Silk Road Maritime Extends Its Global Reach in 2026

Updated Category News Views 5

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

Continue Reading
USPS Honors 150 Years of the U.S. Coast Guard Academy

Updated Category News Views 6

Honoring Tradition and Service The good ol’ U.S. Postal Service is at it again, giving a tip of the hat to a slice of American military heritage. This time, they’re putting out a new stamp to celebrate the 150th anniversary of the U.S. Coast Guard Academy. And you know where they did the honors? Right there on Custom House Pier in New London, Connecticut, a place that...

Continue Reading

Top 5 Most Recently Viewed Articles

Cingulate Inc. Shows Progress with Q2 2025 Financial Results

Updated Category News Views 142

Cingulate Inc. Announced Financial Highlights for Q2 2025 Cingulate Inc. (NASDAQ: CING), a prominent biopharmaceutical company focused on innovative ADHD treatments, recently disclosed its financial results for the second quarter of 2025, alongside significant advancements. Central to the company’s activities was the submission of the New Drug Application (NDA) for its...

Continue Reading
Discover How Your Investment in Carvana Could Have Grown

Updated Category News Views 127

Investment Growth Over Five Years Investing wisely can create remarkable returns over time. A case in point is Carvana Co (NASDAQ: CVNA), which has significantly outperformed expectations in recent years. Over the past five years, Carvana has shown an impressive annualized return of 18.46%, surpassing the market by 4.39% each year. Presently, Carvana's market...

Continue Reading
Deko Cocktails Triumphs with Best New RTD Award Success

Updated Category News Views 92

Deko Cocktails Achieves WSWA Best RTD Award Deko Cocktails, a newly launched line of expertly crafted ready-to-serve cocktails, recently secured a prestigious accolade in the beverage alcohol industry. The company was honored with the Best RTD (Ready to Drink) Product of the Year at the Wine & Spirit Wholesalers of America (WSWA) Brand Battle. This annual competition...

Continue Reading
Bouygues SA Shares and Voting Rights Update for January 2025

Updated Category News Views 205

Key Insights on Bouygues SA's Monthly Share and Voting Rights Bouygues SA regularly updates its shareholders about essential metrics, including the total number of shares and the voting rights attached to them. Understanding these details is vital for investors and stakeholders who wish to stay informed of the company's standing in the market. Transparency in Shareholder...

Continue Reading
Challenges Faced by Oncternal Therapeutics and Stock Update

Updated Category News Views 94

Oncternal Therapeutics Inc. (ONCT) was in dire straits back then, hitting a notable low of $1.31 amidst a turbulent market that left investors biting their nails. This stock plunge represented a hefty drop of -76.33%, rattling traders who were already on edge over the biopharmaceutical company’s struggle to bring innovative cancer therapies to market. The company's...

Continue Reading